Product analysis
Hawthorn 500 mg offers a focused herbal supplement with a clearly named preparation and favorable serving cost.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality40
The hawthorn species and freeze-dried preparation are clearly identified. Those details alone do not establish its absorption or quality advantage.
Ingredient Transparency100
The hawthorn amount and preparation are clearly disclosed. That makes it straightforward to compare with other hawthorn supplements.
Value For Money100
The labeled serving cost compares favorably. That favorable cost does not itself establish the strength of its effects.
Customer Satisfaction70
Customer feedback is generally positive. The small review base leaves wider customer satisfaction less certain.
Product Focus73
The formula stays focused on hawthorn and appears reasonably aligned with its intended goals. Specific benefits are not described clearly enough to promise a particular result.
- Format
Capsule - Container
- 90 Capsule(s)
- Per serving
- $0.23
- Customer rating
- 4.6 · 174 ratings
Goals
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Hawthorn, Freeze-Dried (Crataegus monogyna, Freeze-Dried) | 500 mg |
How this ingredient is rated
Composition and Label Disclosure57
Marker and Preparation Disclosure
Species Name Disclosure
Composition and Label Disclosure
Commercial Price and Usability100
Commercial Price per Labeled Serving
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Real world effectiveness of Hawthorn special extract WS 1442 in a retrospective cohort study from Germany.
- Hawthorn (Crataegus spp.) Clinically Significantly Reduces Blood Pressure in Hypertension: A Meta-Analysis of Randomized Placebo-Controlled Clinical Trials.
- A randomised double blind placebo controlled clinical trial of a standardised extract of fresh Crataegus berries (Crataegisan) in the treatment of patients with congestive heart failure NYHA II.
- [Crataegus Special Extract WS 1442. Assessment of objective effectiveness in patients with heart failure (NYHA II)].
- Prospective, comparative cohort studies and their contribution to the benefit assessments of therapeutic options: heart failure treatment with and without Hawthorn special extract WS 1442.
- [Actions of standardized extracts of Crataegus berries on exercise tolerance and quality of life in patients with congestive heart failure].
- Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials.
- Clinical efficacy of crataegus extract WS 1442 in congestive heart failure NYHA class II.
- Baseline severity but not gender modulates quantified Crataegus extract effects in early heart failure--a pooled analysis of clinical trials.